NSCLCNon-small cell lung cancerEGFR-mutant NSCLC44MRDLUADEGFR mutant NSCLC
…performed a prospective study (n=113) in patients with advanced NSCLC treated with single agent ICIs and correlated clinopathological…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 17,101–17,160 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
second cancer1secondary Sjogren’s syndrome1secondary T-cell malignancy1secondary aldosteronism1secondary antiphospholipid syndrome1secondary arterial hypertension1secondary biliary cirrhosis1secondary cardiovascular events or strokes1secondary cerebral venous sinus thrombosis1secondary headache1secondary headache syndromes1secondary intracranial hypertension1secondary leukaemia1secondary malignancies1secondary malignancies of T-cell origin1secondary ocular surface disease1secondary open angle glaucoma1secondary or early latent syphilis1secondary peripheral T-cell lymphoma1secondary preseptal cellulitis1secretory NET1segmental dystonia1segmental spinal dysgenesis1seizure1seizure-like events1self-harming1self-limiting diseases1sensorineural deafness1sensory deprivation amblyopia1sensory-dominant axonal degeneration polyneuropathy1sepsis shock1sepsis-antimicrobial1sepsis-associated thrombocytopenia (SATP)1sepsis-induced AKI1sepsis-induced new-onset AF1sepsis-related myocardial dysfunction1sepsis/infection1sepsis/meningitis/infection1sepsis21sepsisOutcomeNo1septal panniculitis1septic cardiomyopathy1septic osteomyelitis1septic pelvic thrombophlebitis (SPT)1septic thrombophlebitis of the internal jugular vein1serious life-limiting illnesses1serious life-threatening illnesses1serious mental health conditions1serious mental illness1serious or catastrophic injury1serious pediatric conditions1serious thoracic injury1seronegative DPS1seronegative encephalitis1serous carcinoma1serous cystadenocarcinoma1serous cystic neoplasm1serrated adenomas1serrated lesions1sesamoid necrosis1
Articles mentioning diseases
23,712 articles · page 9 of 1976OPCHPV-positive OPCOropharyngeal squamous cell carcinomaOPCStudyPhase
…y; MDADI, MD Anderson Dysphagia Inventory; ND, neck dissection; OPC, oropharyngeal cancer; RT, radiotherapy; SIB, Simultaneous Inte…
Preeclampsia
… The condition usually resolves within three months postpartum. Preeclampsia affects approximately 3–10% of pregnancies and is a leading cau…
Type 1 diabetesdiabetesgestational diabetes
…ic events among patients with diabetes during Ramadan in Qatar. Type 1 diabetes, a longer diabetes duration (whether type 1 or type 2), a high …
SjDFibromyalgiaSScsystemic sclerosis
…an in SjD (p<0.0001). Sicca symptoms were more prevalent in SSc/SjD compared to SSc (p<0.0001). Interstitial lung disease (ILD) was…
Type 2 diabetes
…ronic fees, costs of yearly tests and self-paid foot screening. Type 2 diabetes drug costs and adverse drug-specific health outcomes are not in…
gonorrhoeasyphilisHIV
…e prevalence of active syphilis was 4.4% (95% CI 3.2% to 6.0%), gonorrhoea was 13.4% (95% CI 11.3% to 15.9%), CT was 20.7% (95% CI 18.2% t…
type 2 diabetes mellitusT2DMCVD
…iflozin, dapagliflozin, canagliflozin and ertugliflozin); T2DM, type 2 diabetes mellitus.The trial emulation cohort had a lower burden of co-prescribed …
osteoarthritisrheumatoid arthritisChronic kidney disease2255Chronic respiratory disease2780chronic kidney diseaseCardiac disease6880Rheumatoid arthritis1255covid-19chronic respiratory disease
…ibed opioids. They were also more likely to have a diagnosis of osteoarthritis than those not prescribed opioids (52.2% v 32.1%; table 1) and …
prostate cancerMerkel cell carcinomasmall cell lung cancerbreast cancerneuroendocrine tumours
…-phase development to practice-changing trials, particularly in prostate cancer and neuroendocrine tumours. 51 In prostate cancer, the phase II…
advanced RCCRCCICI-responsive tumours
…umour and immune adaptation during ICI therapy in patients with advanced RCC reported opposing findings where responder tumours showed incre…